M&A Deal Summary

Ridgemont Equity Partners Acquires Gallus Biopharmaceuticals

On May 18, 2011, private equity firm Ridgemont Equity Partners acquired life science company Gallus Biopharmaceuticals

Acquisition Highlights
  • This is Ridgemont Equity Partners’ 1st transaction in the Life Science sector.
  • This is Ridgemont Equity Partners’ 66th transaction in the United States.
  • This is Ridgemont Equity Partners’ 1st transaction in Montana.
Investment Fate
  • Gallus Biopharmaceuticals was sold to a strategic buyer in 2014.

M&A Deal Summary

Date 2011-05-18
Target Gallus Biopharmaceuticals
Sector Life Science
Buyer(s) Ridgemont Equity Partners
Deal Type Buyout (LBO, MBO, MBI)

Target

Gallus Biopharmaceuticals

St. Louis, Montana, United States
Gallus BioPharmaceuticals is a contract manufacturing company offering exceptional contract services to its clients. Gallus’ world-class facility in St. Louis is distinguished by nearly three decades of biologics development and over a decade of commercial cGMP manufacturing, including the ongoing manufacture of Remicade® and Stelara® for Janssen Pharmaceuticals.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Ridgemont Equity Partners

Charlotte, North Carolina, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1993
PE ASSETS 7.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Ridgemont Equity Partners is an independent private equity firm specializing in middle-market buy-outs, corporate divestitures, recapitalizations and growth capital investments. The Firm targets to invest in companies located in North America, preferably in US and Canada. REP looks to invest up to $500 million in companies with EBIDTA of $5 - $50 million. The Firm seeks to hold both majority and minority equity interest in portfolio companies. Specific areas of interest include basin industries and services, energy, healthcare, telecommunications, media and technology. Ridgemont Equity Partners is a spun-off of Banc of America Capital Investors (BACI). Ridgemont Equity Partners was formed in August 2010 and is based in Charlotte, North Carolina.


DEAL STATS #
Overall 80 of 136
Sector: Life Science M&A 1 of 1
Type: Buyout (LBO, MBO, MBI) M&A Deals 37 of 58
State: Montana M&A 1 of 1
Country: United States M&A 66 of 121
Year: 2011 M&A 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-03-10 HCA Healthcare

Nashville, Tennessee, United States

HCA Healthcare is a national healthcare service provider. HCA operates general and acute care hospitals with a full range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. Outpatient and ancillary health care services are provided by general, acute care hospitals, freestanding surgery centers, diagnostic centers, and rehabilitation facilities. HCA's psychiatric hospitals provide a full range of mental health care services through inpatient, partial hospitalization and outpatient settings. HCA Healthcare was formed in 1968 and is based in Nashville, Tennessee.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-07-14 Aurora Parts & Accessories

Lebanon, Indiana, United States

Aurora Parts & Accessories is a distributor of aftermarket parts and accessories for over-the-road semi-trailers. The company offers a complete line of branded and private label parts in the industry, maintaining a comprehensive inventory to serve all makes and models of trailer. Aurora Parts & Accessories is based in Lebanon, Indiana.

Buy -